{{Rsnum
|rsid=2842483
|Gene=PCSK5
|Chromosome=9
|position=76291234
|Orientation=minus
|GMAF=0.2268
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PCSK5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 40.7 | 52.2
| HCB | 0.0 | 13.9 | 86.1
| JPT | 0.0 | 18.6 | 81.4
| YRI | 8.2 | 43.2 | 48.6
| ASW | 8.8 | 54.4 | 36.8
| CHB | 0.0 | 13.9 | 86.1
| CHD | 0.0 | 23.4 | 76.6
| GIH | 0.0 | 20.8 | 79.2
| LWK | 15.5 | 37.3 | 47.3
| MEX | 1.7 | 39.7 | 58.6
| MKK | 12.3 | 41.9 | 45.8
| TSI | 6.9 | 44.1 | 49.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (age of onset)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000005
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs2842483
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 9q21.13; Reported Gene(s): RFK; Risk Allele: rs2842483-?); (p-value= 0.000005).This variant is associated with Multiple sclerosis (age of onset).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740724
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2842483
|overall_frequency_n=43
|overall_frequency_d=128
|overall_frequency=0.335938
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=34
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}